Improvements of Drug-resistant Species To Emerge as Key Opportunity for Companies Dealing with E-coli Testing Market
The contamination of food and water supplies with disease-causing elements has become a common problem in many regions across the globe. However, at times, detecting such disease-causing organisms can be a bit tricky. Water and food that seems to be clean and safe to drink and eat, may actually be contaminated with extremely dangerous viruses, parasites, and bacteria. Water and food samples are commonly tested for E.coli in order to avoid water and food-borne infections.
Environmental and drinking water is regulated by the environmental protection agency (EPA), while the food and drug administration (FDA) regulates bottled water standards. Environmental e-coli testing methods comprise of multiple tube fermentation, enzyme substrate, and membrane filtration methods. The demand for accurate and rapid test kits is increasing owing to the recurrent outbreaks of E.coli infections. Some of the testing methods for E.coli detection include enzyme immunoassay, polymerase chain reaction, and others. At present, the enzyme immunoassay kits segment leads the global market for E.coli testing.
According to the new report published by Transparency Market Research (TMR), the global E.coli testing market was valued at US$1.2 bn in 2013 and is expected to reach US$2.1 bn by 2022, progressing at a 6.58% CAGR from 2014 to 2022.
TMR analysts answers a few questions that key organizations operating in the global E.coli market might ask:
Q. What are the factors expected to drive the global E.coli testing market?
The global market for E.coli testing is primarily driven by the rising incidence of E.coli and high rate of illness associated with it. Going forward the improvement of drug-resistant species is also predicted to propel the global market. Government support, in the form of rising funding, is also expected to benefit the market in the near future. However, it is expected that the global market will be hampered by high cost associated with the tests.
Q. How will rising outbreak of E.coli infections propel global E.Coli testing market?
In 2011, in Germany, a major eruption of E.coli 0104:H4 strain was registered in which 1,000 cases of EHEC and 500 cases of the hemolytic-uremic syndrome were recorded. The epidemic was spread to various parts of Europe such as France, Denmark, Austria, Sweden, Netherlands, Spain, the United Kingdom, and Norway. This outbreak of E.coli infection boosted the demand for E.coli testing solutions.
Q. How will new product launch benefit the global market?
Many companies introduced new E.coli testing methods to cure E.coli infections across various regions.
Recently, Roberts Research Institute, based in Canada, developed new test to rapidly detect E.coli infections in food. The new test detects E.coli 0157 food borne bacteria. The test allows food manufacturers to quickly identify contaminated food.
Key companies operating in the global E.coli testing market are focusing on introducing E.coli testing methods to maintain their dominance. Some of the key players operating in the global market are IDEXX Laboratories, HyServe GmbH & Co. KG, Abbott Laboratories, Dickinson and Company, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Charm Sciences, and CPI International.
Developing economies in Latin America and Asia Pacific are currently identified as the most promising markets globally. In these regions, most of the tests are performed by using individual lab consumables and apparatus. However, 40% of the tests are performed by using easy-to-use kits. At present, China is taking efforts to improve its infrastructure to introduce innovative E.coli tests.
E.coli testing finds application in hospitals, diagnostic laboratories, and physician offices.